<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-135720</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Perpiñá Tordera, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Arch Bronconeumol;41(supl.2): 15-20, mayo 2005. tab, graf</dc:source>
<dc:identifier>ibc-135720</dc:identifier>
<dc:title xml:lang="es">¿Agonistas adrenérgicos beta2 de acción prolongada como primera elección?</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2021^s22073</dc:subject>
<dc:subject>^d321^s22073</dc:subject>
<dc:subject>^d36008^s22057</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d13946^s22073</dc:subject>
<dc:subject>^d3706^s22073</dc:subject>
<dc:subject>^d32129^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200505</dc:date>
</metadata>
</record>
</ibecs-document>
